Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

The G-protein-coupled formylpeptide receptor FPR confers a more invasive phenotype on human glioblastoma cells.

Huang J, Chen K, Chen J, Gong W, Dunlop NM, Howard OM, Gao Y, Bian XW, Wang JM.

Br J Cancer. 2010 Mar 16;102(6):1052-60. doi: 10.1038/sj.bjc.6605591. Epub 2010 Mar 2.

2.

Regulation of the leucocyte chemoattractant receptor FPR in glioblastoma cells by cell differentiation.

Huang J, Chen K, Huang J, Gong W, Dunlop NM, Howard OM, Bian X, Gao Y, Wang JM.

Carcinogenesis. 2009 Feb;30(2):348-55. doi: 10.1093/carcin/bgn266. Epub 2008 Nov 26.

3.

G-protein coupled chemoattractant receptors and cancer.

Huang J, Chen K, Gong W, Dunlop NM, Wang JM.

Front Biosci. 2008 May 1;13:3352-63. Review.

PMID:
18508437
4.

Cooperation between NOD2 and Toll-like receptor 2 ligands in the up-regulation of mouse mFPR2, a G-protein-coupled Abeta42 peptide receptor, in microglial cells.

Chen K, Zhang L, Huang J, Gong W, Dunlop NM, Wang JM.

J Leukoc Biol. 2008 Jun;83(6):1467-75. doi: 10.1189/jlb.0907607. Epub 2008 Feb 25.

PMID:
18299458
5.

Toll-like receptors in inflammation, infection and cancer.

Chen K, Huang J, Gong W, Iribarren P, Dunlop NM, Wang JM.

Int Immunopharmacol. 2007 Oct;7(10):1271-85. Epub 2007 Jun 21. Review.

PMID:
17673142
6.

Transactivation of the epidermal growth factor receptor by formylpeptide receptor exacerbates the malignant behavior of human glioblastoma cells.

Huang J, Hu J, Bian X, Chen K, Gong W, Dunlop NM, Howard OM, Wang JM.

Cancer Res. 2007 Jun 15;67(12):5906-13.

7.

Induction of the formyl peptide receptor 2 in microglia by IFN-gamma and synergy with CD40 ligand.

Chen K, Iribarren P, Huang J, Zhang L, Gong W, Cho EH, Lockett S, Dunlop NM, Wang JM.

J Immunol. 2007 Feb 1;178(3):1759-66.

8.

Activation of Toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid beta peptide.

Chen K, Iribarren P, Hu J, Chen J, Gong W, Cho EH, Lockett S, Dunlop NM, Wang JM.

J Biol Chem. 2006 Feb 10;281(6):3651-9. Epub 2005 Dec 9.

9.

Synthetic peptide MMK-1 is a highly specific chemotactic agonist for leukocyte FPRL1.

Hu JY, Le Y, Gong W, Dunlop NM, Gao JL, Murphy PM, Wang JM.

J Leukoc Biol. 2001 Jul;70(1):155-61.

PMID:
11435499
10.

Amyloid (beta)42 activates a G-protein-coupled chemoattractant receptor, FPR-like-1.

Le Y, Gong W, Tiffany HL, Tumanov A, Nedospasov S, Shen W, Dunlop NM, Gao JL, Murphy PM, Oppenheim JJ, Wang JM.

J Neurosci. 2001 Jan 15;21(2):RC123.

11.

Novel pathophysiological role of classical chemotactic peptide receptors and their communications with chemokine receptors.

Le Y, Li B, Gong W, Shen W, Hu J, Dunlop NM, Oppenheim JJ, Wang JM.

Immunol Rev. 2000 Oct;177:185-94. Review.

PMID:
11138775
12.

Expression of functional formyl peptide receptors by human astrocytoma cell lines.

Le Y, Hu J, Gong W, Shen W, Li B, Dunlop NM, Halverson DO, Blair DG, Wang JM.

J Neuroimmunol. 2000 Nov 1;111(1-2):102-8.

PMID:
11063827
13.

N36, a synthetic N-terminal heptad repeat domain of the HIV-1 envelope protein gp41, is an activator of human phagocytes.

Le Y, Jiang S, Hu J, Gong W, Su S, Dunlop NM, Shen W, Li B, Ming Wang J.

Clin Immunol. 2000 Sep;96(3):236-42.

PMID:
10964542
14.

A burgeoning family of biological mediators: chemokines and chemokine receptors.

Le Y, Gong W, Shen W, Li B, Dunlop NM, Wang JM.

Arch Immunol Ther Exp (Warsz). 2000;48(3):143-50. Review.

PMID:
10912618
15.

A new insight into the role of "old" chemotactic peptide receptors FPR and FPRL1: down-regulation of chemokine receptors CCR5 and CXCR4.

Le Y, Shen W, Li B, Gong W, Dunlop NM, Wang JM.

Forum (Genova). 1999 Oct-Dec;9(4):299-314. Review.

PMID:
10611407
18.
19.

Epitopes recognized by the neutralizing antibodies of an HIV-1-infected individual.

Profy AT, Salinas PA, Eckler LI, Dunlop NM, Nara PL, Putney SD.

J Immunol. 1990 Jun 15;144(12):4641-7.

PMID:
1693639
20.

Synthetic CD4 peptide derivatives that inhibit HIV infection and cytopathicity.

Lifson JD, Hwang KM, Nara PL, Fraser B, Padgett M, Dunlop NM, Eiden LE.

Science. 1988 Aug 5;241(4866):712-6.

PMID:
2969619
21.

Purified envelope glycoproteins from human immunodeficiency virus type 1 variants induce individual, type-specific neutralizing antibodies.

Nara PL, Robey WG, Pyle SW, Hatch WC, Dunlop NM, Bess JW Jr, Kelliher JC, Arthur LO, Fischinger PJ.

J Virol. 1988 Aug;62(8):2622-8.

22.
23.

Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody.

Nara PL, Hatch WC, Dunlop NM, Robey WG, Arthur LO, Gonda MA, Fischinger PJ.

AIDS Res Hum Retroviruses. 1987 Fall;3(3):283-302.

PMID:
3481271
24.

Generation of thymotropic envelope gene recombinant virus and induction of lymphoma by ecotropic Moloney murine leukemia virus.

Fischinger PJ, Dunlop NM, Robey WG, Schäfer W.

Virology. 1985 Apr 15;142(1):197-205.

PMID:
4060571
25.

Pathogenesis and virus content of lymphomas induced by pure ecotropic Graffi murine leukemia virus.

Fischinger PJ, Dunlop NM, Robey WG.

Int J Radiat Oncol Biol Phys. 1985 Feb;11(2):241-51.

PMID:
2982768
26.

The role of viral and cellular recombinational events in murine leukemia.

Fischinger PJ, Dunlop NM, Dekaban GA, Robey WG.

Transplant Proc. 1984 Apr;16(2):428-34. No abstract available.

PMID:
6326352
27.

Generation of recombinant murine leukemia viruses de novo: an alternative model for leukemogenesis.

Fischinger PJ, Dunlop NM, Poore CM, Robey WG.

Haematol Blood Transfus. 1983;28:261-9.

PMID:
6305796
28.

Presence of a novel recombinant murine leukemia virus-like glycoprotein on the surface of virus-negative C57BL lymphoma cells.

Fischinger PJ, Thiel HJ, Lieberman M, Kaplan HS, Dunlop NM, Robey WG.

Cancer Res. 1982 Nov;42(11):4650-7. No abstract available.

29.

Persistence of one species of oncovirus in mixed infection after antiserum treatment or transspecies rescue.

Fischinger PJ, Robey WG, Blair DG, Blevins CS, Dunlop NM.

J Gen Virol. 1982 Oct;62 (Pt 2):393-8.

PMID:
7142977
30.

XVIII. Effective treatment of AKR leukemia with antibody to gp7 1 eliminates the neonatal burst of ecotropic AKR virus producing cells.

Fischinger PJ, Dunlop NM, Schwarz H, Ihle JN, Weinhold K, Bolognesi DP, Schafer W.

Virology. 1982 May;119(1):68-81. No abstract available.

PMID:
6280386
31.
32.

Further characterization of the oncornavirus inactivating factor in normal mouse serum.

Montelaro RC, Fischinger PJ, Larrick SB, Dunlop NM, Ihle JN, Frank H, Schäfer W, Bolognesi DP.

Virology. 1979 Oct 15;98(1):20-34. No abstract available.

PMID:
225862
33.

Genomic masking of nondefective recombinant murine leukemia virus in Moloney virus stocks.

Fischinger PJ, Blevins CS, Dunlop NM.

Science. 1978 Aug 4;201(4354):457-9.

PMID:
663667
34.

Identification of virus found in mouse lymphomas induced by HIX murine oncornavirus.

Fischinger PJ, Dunlop NM, Blevins CS.

J Virol. 1978 May;26(2):532-5.

35.

Relationships between structure and activity of retinoids.

Sporn MB, Dunlop NM, Newton DL, Henderson WR.

Nature. 1976 Sep 9;263(5573):110-3.

PMID:
987541
36.

Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids).

Sporn MB, Dunlop NM, Newton DL, Smith JM.

Fed Proc. 1976 May 1;35(6):1332-8. Review.

PMID:
770206
37.

Activity of vitamin A analogues in cell cultures of mouse epidermis and organ cultures of hamster trachea.

Sporn MB, Clamon GH, Dunlop NM, Newton DL, Smith JM, Saffiotti U.

Nature. 1975 Jan 3;253(5486):47-50. No abstract available.

PMID:
1110749
38.

Supplemental Content

Loading ...
Support Center